X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (32) 32
humans (27) 27
female (18) 18
aged (17) 17
hematology (16) 16
male (16) 16
middle aged (13) 13
oncology (13) 13
lymphomas (12) 12
rituximab (12) 12
adult (11) 11
abridged index medicus (10) 10
cancer (9) 9
lymphoma (9) 9
therapy (8) 8
transplantation (8) 8
waldenstrom macroglobulinemia - drug therapy (8) 8
animals (7) 7
b-cell lymphoma (7) 7
disease-free survival (7) 7
mutation (7) 7
treatment outcome (7) 7
aged, 80 and over (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
article (6) 6
chronic lymphocytic-leukemia (6) 6
ibrutinib (6) 6
leukemia (6) 6
lymphocytes b (6) 6
patients (6) 6
waldenstrom macroglobulinemia - genetics (6) 6
antigens (5) 5
astronomy & astrophysics (5) 5
bone marrow (5) 5
care and treatment (5) 5
mice (5) 5
myd88 l265p (5) 5
pyrazoles - therapeutic use (5) 5
pyrimidines - therapeutic use (5) 5
t cells (5) 5
tumors (5) 5
young adult (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (4) 4
apoptosis (4) 4
chemotherapy (4) 4
cxcr4 (4) 4
disease (4) 4
drug therapy (4) 4
hemic and lymphatic diseases (4) 4
malignancies (4) 4
medical research (4) 4
medicine, research & experimental (4) 4
neutropenia (4) 4
non-hodgkins-lymphoma (4) 4
prognosis (4) 4
receptors, cxcr4 - genetics (4) 4
recurrence (4) 4
stem-cell transplantation (4) 4
time factors (4) 4
activation (3) 3
antigens, neoplasm - immunology (3) 3
antineoplastic agents - therapeutic use (3) 3
astrophysics (3) 3
chemotherapy, adjuvant (3) 3
clinical trials (3) 3
complications and side effects (3) 3
dexamethasone (3) 3
drug resistance, neoplasm - genetics (3) 3
gemcitabine (3) 3
hematology, oncology and palliative medicine (3) 3
hematopoietic stem cells (3) 3
immunoglobulin m - blood (3) 3
immunology (3) 3
immunotherapy (3) 3
in-vivo (3) 3
l265p somatic mutation (3) 3
lymphocytes (3) 3
macroglobulinemia (3) 3
maximum tolerated dose (3) 3
medicine, general & internal (3) 3
mice, inbred balb c (3) 3
multicenter (3) 3
myd88 (3) 3
myeloid differentiation factor 88 - genetics (3) 3
neoplasm transplantation (3) 3
open-label (3) 3
physics (3) 3
physics, particles & fields (3) 3
prospective studies (3) 3
protein kinase inhibitors - therapeutic use (3) 3
protein-tyrosine kinases - antagonists & inhibitors (3) 3
pyrazoles - adverse effects (3) 3
pyrimidines - adverse effects (3) 3
randomized-trial (3) 3
regimen (3) 3
research (3) 3
research article (3) 3
resistance (3) 3
stem cells (3) 3
survival (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 3545 - 3545
Abstract Background: Relapsed/refractory (R/R) DLBCL is associated with high healthcare resource utilization (HRU) and cost (Danese 2017). Patients with R/R... 
Journal Article
Best Practice & Research: Clinical Haematology, ISSN 1521-6926, 2016
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 03/2019, Volume 25, Issue 3, pp. S402 - S403
Lymphoplasmacytic lymphoma (LPL) is associated with production of monoclonal paraproteins. Rarely, these paraproteins misfold, aggregate and form amyloid... 
Antimitotic agents | Bone marrow | Transplantation | Amyloidosis | Antineoplastic agents | Hematopoietic stem cells | Tumors
Journal Article
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting, 01/2019, Volume 39, Issue 39, pp. 446 - 453
Aggressive B-cell lymphomas that are primary refractory to, or relapse after, frontline chemoimmunotherapy have a low cure rate with conventional therapies.... 
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 04/2015, Volume 372, Issue 15, pp. 1430 - 1440
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 2991 - 2991
Abstract Background:Epigenetic manipulation and immunomodulation are therapeutic strategies in hematologic malignancies. In our previous study, the combination... 
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 3, pp. 284 - 292
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 08/2018, Volume 67, Issue 5, pp. 687 - 692
Abstract Background Ibrutinib is a Bruton tyrosine kinase inhibitor that is used for the treatment of lymphoid cancers, including chronic lymphocytic leukemia,... 
ibrutinib | infection | invasive fungal infection | INFECTIOUS DISEASES | X-LINKED AGAMMAGLOBULINEMIA | MICROBIOLOGY | INVASIVE FUNGAL-INFECTIONS | IMMUNOLOGY | TARGETING BTK | SINGLE-AGENT IBRUTINIB | BRUTONS TYROSINE KINASE | TREATMENT-NAIVE | THERAPY | PNEUMOCYSTIS-JIROVECII PNEUMONIA | B-CELL MALIGNANCIES | CHRONIC LYMPHOCYTIC-LEUKEMIA | and Commentaries
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 06/2018, Volume 378, Issue 25, pp. 2399 - 2410
Journal Article
Journal Article
Cancer Discovery, ISSN 2159-8274, 09/2017, Volume 7, Issue 9, pp. 1018 - 1029
Journal Article
Molecular Therapy, ISSN 1525-0016, 11/2018, Volume 26, Issue 11, pp. 2542 - 2552
CD19 chimeric antigen receptors (CARs) have demonstrated great efficacy against a range of B cell malignancies. However, antigen escape and, more generally,... 
antigen escape | pancreatic cancer | radiation | sialyl Lewis-A | CAR T cell | CAR T cell | MEDICINE, RESEARCH & EXPERIMENTAL | B-ALL | DESIGN | THERAPY | EFFICACY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GENETICS & HEREDITY | ANTIBODY | TUMORICIDAL ACTIVITY | DEATH | MEDIATE | PROMOTES | Humans | Antigens, Neoplasm - radiation effects | Radiation | Antigens, Neoplasm - chemistry | Pancreatic Neoplasms - drug therapy | Antigens, CD19 - therapeutic use | Oligosaccharides - chemistry | Antigens, CD19 - immunology | Disease Models, Animal | Immunotherapy, Adoptive | Antigens, Neoplasm - immunology | Oligosaccharides - therapeutic use | Pancreatic Neoplasms - radiotherapy | Pancreatic Neoplasms - genetics | Combined Modality Therapy | Radiation Dosage | TNF-Related Apoptosis-Inducing Ligand - immunology | Insulin-Secreting Cells - immunology | Receptors, Chimeric Antigen - therapeutic use | Animals | Sequence Analysis, RNA | Oligosaccharides - immunology | Pancreatic Neoplasms - immunology | Receptors, Chimeric Antigen - immunology | Mice | TNF-Related Apoptosis-Inducing Ligand - genetics | Insulin-Secreting Cells - radiation effects | Adenocarcinoma | Antigens | CD19 antigen | Transcription | Laboratories | Tumor cells | Genomics | Lymphocytes T | Ribonucleic acid--RNA | Experiments | Cancer therapies | Beta cells | Cellular biology | Lymphocytes | Pancreatic cancer | Solid tumors | Pancreas | Tumors | Original
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 20, pp. 3397 - 3398
Journal Article
British Journal of Haematology, ISSN 0007-1048, 03/2016, Volume 172, Issue 5, pp. 735 - 744
Journal Article
Blood, ISSN 0006-4971, 11/2017, Volume 130, Issue 20, pp. 2196 - 2203
Journal Article